Pain News and Research

Latest Pain News and Research

Study finds early surgical treatment may benefit people who suffer from biceps injuries

People who suffer from injuries to the distal biceps tendon may benefit from earlier surgical intervention and new surgical techniques, according to a review article published in the March 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

3 Mar 2010

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Bristol-Myers Squibb Company and Allergan, Inc. today announced a global agreement for the development and commercialization of AGN-209323, a Phase II-ready, orally administered small molecule in clinical development for neuropathic pain.

3 Mar 2010

POZEN reports net loss of $6.9M for year ended December 31, 2009

POZEN Inc., today announced results for the fourth quarter and year ended December 31, 2009.

3 Mar 2010

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

3 Mar 2010

Total economic impact of foodborne illness across the nation to be a combined $152 billion annually

A new study by a former U.S. Food and Drug Administration (FDA) economist estimates the total economic impact of foodborne illness across the nation to be a combined $152 billion annually.

3 Mar 2010

Harvard Professor urges medical community to use ultrasound for diagnosing acute female pelvic conditions

In a bold, eye-opening editorial in the March 2010 issue of the Journal of Ultrasound in Medicine, Harvard Professor, Beryl Benacerraf, MD, urges the medical community to use ultrasound instead of Computed Tomography (CT) as the first-line imaging test for better diagnosis capability in the evaluation of acute female pelvic and lower abdominal conditions.

3 Mar 2010

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it had added five new prescription drugs to its products delivered through its national sales channels.

3 Mar 2010

New dental device takes fear and pain out of anesthetic injections

DentalVibe™ a new dental device now on the market takes the fear and pain out of dental injections. The product design firm, Bresslergroup, teamed with Dr. Steven G. Goldberg, DDS, to design the easy to use tool. Research shows that fear of a painful anesthetic injection keeps 50% of the patient population away from the dentist.

3 Mar 2010

Vidacare's OnControl Bone Marrow System now available for bone marrow procedures

For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient’s skin and bone, and the procedure is often described as “brutal,” “excruciating” and even “barbaric.”

3 Mar 2010

Aurora Health Care establishes new clinic for treating chronic vulvar pain

It is a sensitive subject for many women. The issue is chronic vulvar pain, and it impacts one out of six women at some point in their lives. However, most women are unaware of their treatment options.

3 Mar 2010

Exactech receives FDA marketing clearance for Equinoxe Platform Fracture Stem

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company’s Equinoxe® Platform Fracture Stem, the latest addition to the company’s shoulder arthroplasty line.

3 Mar 2010

Phase III study results of Merck's allergy immunotherapy tablet

In new data from a Phase III study in 345 children and adolescents (ages 5-17 years), patients with grass pollen allergic rhinoconjunctivitis treated with Merck's investigational sublingual grass (Phleum Pratense) allergy immunotherapy tablet (AIT) showed a 26 percent greater improvement in the total combined score (daily symptom score and daily medication score), compared to patients receiving placebo

3 Mar 2010

Increasing health costs hurt coverage of medical workers, too

Even members of the health industry are feeling the pain of increasing health costs as they insure their employees, according to the Detroit News. "To combat rising costs, major health organizations are trimming medical benefits, tacking on surcharges for smoking and passing more out-of-pocket costs onto workers. Nurses, technicians and hospital workers are paying higher copayments and deductibles. … For many health providers, these cost-containing moves come out of necessity. They, too, have seen business taper off as a result of the recession, with many of their own patients losing coverage because of job losses."

3 Mar 2010

OrthoDynamix' ArthroSteer 3.5mm Ablator for general surgical use receives FDA clearance

OrthoDynamix announced today that it has received FDA clearance for its new device, ArthroSteer 3.5mm Ablator, a mono polar electrosurgical device, for general surgical use, including the orthopedic and arthroscopic applications for resection, ablation, excision of soft tissue, hemostasis of blood vessels, and coagulating soft tissue in, but not limited to the knee, shoulder, and primarily the hip.

3 Mar 2010

Doctors issue warnings about reduced access as Congressional inaction cuts Medicare pay

A political deadlock in the Senate has triggered a 21 percent Medicare pay reduction to doctors who say they may have to limit care for older Americans unless the reduction is reversed.

2 Mar 2010

Cause of abdominal pain in children with no apparent reason: Psychosomatic component

A systematic review that is published in the current issue of Psychotherapy and Psychosomatics by Schulte and associates (University of Bremen, Germany) analyzes what is the psychosomatic component of abdominal pain with no apparent cause in children.

2 Mar 2010

MAP Pharmaceuticals announces net loss of $13.4M for fourth-quarter 2009

MAP Pharmaceuticals, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.

2 Mar 2010

FDA approves CombinatoRx's NDA for Exalgo extended-release tablets

CombinatoRx, Incorporated today announced that the U.S. Food and Drug Administration has approved the New Drug Application (NDA) for Exalgo™ (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

2 Mar 2010

French investigation explores the outcome of physical functioning of coronary angioplasty

A French investigation published in the current issue of Psychotherapy and Psychosomatics has explored the outcome in terms of physical functioning of coronary angioplasty.

2 Mar 2010

IMAI reaches agreement in principal to acquire Organic Science for $15M

International Merchant Advisors, Inc. www.imaiinc.com announced today that the company has reached an agreement in principal to acquire its first operating business in the clinical medical marijuana space. IMAI has agreed to acquire Organic Science, Inc. for $15 million in the restricted common stock of IMAI.

2 Mar 2010

Pain News and Research

Latest Pain News and Research

Study finds early surgical treatment may benefit people who suffer from biceps injuries

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

POZEN reports net loss of $6.9M for year ended December 31, 2009

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Total economic impact of foodborne illness across the nation to be a combined $152 billion annually

Harvard Professor urges medical community to use ultrasound for diagnosing acute female pelvic conditions

Lotus Pharmaceuticals adds five new prescription drugs to its products

New dental device takes fear and pain out of anesthetic injections

Vidacare's OnControl Bone Marrow System now available for bone marrow procedures

Aurora Health Care establishes new clinic for treating chronic vulvar pain

Exactech receives FDA marketing clearance for Equinoxe Platform Fracture Stem

Phase III study results of Merck's allergy immunotherapy tablet

Increasing health costs hurt coverage of medical workers, too

OrthoDynamix' ArthroSteer 3.5mm Ablator for general surgical use receives FDA clearance

Doctors issue warnings about reduced access as Congressional inaction cuts Medicare pay

Cause of abdominal pain in children with no apparent reason: Psychosomatic component

MAP Pharmaceuticals announces net loss of $13.4M for fourth-quarter 2009

FDA approves CombinatoRx's NDA for Exalgo extended-release tablets

French investigation explores the outcome of physical functioning of coronary angioplasty

IMAI reaches agreement in principal to acquire Organic Science for $15M

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Pain News and Research

Latest Pain News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in